Medicine
fromNews Center
10 hours agoExperimental Drug Lowers Parkinson's-Linked Protein in Early Trial - News Center
BIIB094, an experimental drug targeting LRRK2, shows promise in safely reducing gene activity linked to Parkinson's disease in a clinical trial.